medline.ch ORL Hals

	Advances in immunotherapy and targeted therapy for nasopharyngeal carcinoma: Current progress and combined approaches (Review). Oncol Rep Yang Z, Liu H, Chen M, Zhang L, Gong M, Yu R. PMID: 41789645 [PubMed - indexed for MEDLINE]
	Synergistic carcinogenesis of the nasopharyngeal microbiome and Epstein-Barr virus: mechanisms of metabolic reprogramming and immune evasion. Front Immunol Shen S, Li J, Zheng S, Cui X, Gou X. PMID: 41782866 [PubMed - indexed for MEDLINE]
	Swallowing-related outcomes and organ-at-risk dosimetry after proton versus photon radiotherapy in nasopharyngeal carcinoma. Oral Oncol Huang YJ, Fang KC, Tsai MH, Chuang HC, Chien CY, Lin YT, Yang CH, Su YY, Tsai WL, Fang FM. PMID: 41771231 [PubMed - indexed for MEDLINE]
	Role of Prognostic Nutritional Index and C-Reactive Protein/Albumin Ratio in Prognosis of Locally Advanced Nasopharyngeal Carcinoma. Medicina (Kaunas) Kantar TG, Do, Demirel BÇ, Özdemir M, Ta, Y, Özel GS, Çiçek CM, Ta, Demiray AG, De, Yaren A, Gököz Do. PMID: 41752776 [PubMed - indexed for MEDLINE]
	Extracellular Vesicles: A Multidimensional Role in the Occurrence and Development of Nasopharyngeal Carcinoma. Biomolecules Chen H, Huang H, Qu S. PMID: 41750341 [PubMed - indexed for MEDLINE]
	Nasopharyngeal Carcinoma at the Virology Precision Oncology Nexus: Decoding Molecular Alterations for Early Intervention and Therapeutic Innovation. Biomolecules Liu N, Meng B, Li Y, Tang M, Cao Y, Shang L, Shi F. PMID: 41750326 [PubMed - indexed for MEDLINE]
	Efficacy of radiotherapy to metastatic lesion in de novo metastatic nasopharyngeal carcinoma patients: A multicenter, propensity score matching study. Oral Oncol Zhao ZY, He SQ, Liu GY, Lv SH, Yu YH, Zhang GY, Peng DS, Bei WX, Chen CL, Huang Y, Xiang YQ, Wang L. PMID: 41747458 [PubMed - indexed for MEDLINE]
	Predicting induction chemotherapy response based on tumor-stroma ratio and pretreatment synthetic MRI in nasopharyngeal carcinoma. Eur Radiol Exp Ren H, Zhang X, Xu Q, Liu D, Chen X, Huang Y, Lan H, Li L, Li Y, Huang H, Sui J, Huang J, Ren X, Huang Y, Tan Y, Yu H, Shu X, Wang Y, Zhang H, Li D, Nie L, Zhang J. PMID: 41733841 [PubMed - indexed for MEDLINE]
	Prospective Head-to-Head Comparison of (18)F-FDG and (68)Ga-FAPI PET/CT in De Novo and Recurrent Epstein-Barr Virus-associated Nasopharyngeal Carcinoma. Radiol Imaging Cancer Gu B, Lin S, Bai L, Hu C, Ou X, Yang Z, Song S. PMID: 41718535 [PubMed - indexed for MEDLINE]
	Epidemiological study on nasopharyngeal cancer in Morocco: Case of the University Hospital Center Mohammed VI in Marrakech. Tunis Med Anejdam K, Maamri A. PMID: 41712797 [PubMed - indexed for MEDLINE]
	Low-dose fractionated radiotherapy combined with induction chemotherapy in high-risk nasopharyngeal carcinoma: An open-label, randomized phase 2 trial. Oral Oncol Fan M, Yin Q, Li L, Lian Q, Tang Y, Yan L, Xu J, Huang Y, Wang H, Li H, Zhou Q, Ahmed MM, Lang J, Feng M. PMID: 41702154 [PubMed - indexed for MEDLINE]
	Safety and Efficacy of Salvage Treatment for Recurrent Nasopharyngeal Carcinoma: A Single-Center Retrospective Study Over 10â€‰Years. Cancer Med Luo Y, Cai B, Li B, Du L, Ma L. PMID: 41692431 [PubMed - indexed for MEDLINE]
	An 18F-FDG PET/CT-based radiomics nomogram for predicting progression-free survival in nasopharyngeal carcinoma: A retrospective cohort study. Medicine (Baltimore) Lin J, Liu J, Liu Y, Cao Z, Wen D, Wu Y, Wang Z, Zhang X, Wang B, Li S, Dong X. PMID: 41686550 [PubMed - indexed for MEDLINE]
	Standard chemoradiotherapy with concurrent and adjuvant camrelizumab in patients with high risk nasopharyngeal carcinoma: multicentre, randomised, open label, phase 3 trial. BMJ You R, Xu GQ, Ding X, Liang JH, Liu ZG, Zou X, Liu YP, Hu GY, Liu YM, Duan CY, Liu LZ, Zhang WJ, Liu Q, Li HF, Ouyang YF, Duan XT, Wang Q, Peng L, Liang JL, Feng ZK, Qin ZH, Liu X, He ZK, Zhang B, Long GX, Jiang YH, Lei F, Huang PY, Hua YJ, Chen MY. PMID: 41667193 [PubMed - indexed for MEDLINE]
	USP18 orchestrates malignant progression in nasopharyngeal carcinoma through UBR5-driven attenuation of p53 signaling. Int Immunopharmacol Yi Q, Wang D, Zhong K, Chen Z, An J, Ouyang X, Zhu W, Xin Y, Zhong J. PMID: 41633015 [PubMed - indexed for MEDLINE]
	Refining M1-Stage Stratification in De Novo Metastatic Nasopharyngeal Carcinoma Using 18F-FDG PET/CT: Preliminary Evidence. Clin Nucl Med Chen SH, Cheng NM, Fan KS, Chang PH, Lee LA, Huang SF, Kang CJ, Shen EY, Chang KP, Wu PW, Lien KH, Fang TJ, Cheng AJ, Chang JT. PMID: 41632574 [PubMed - indexed for MEDLINE]
	Analysis of Plasma Epstein-Barr Virus DNA and Clinical Outcomes to Pembrolizumab or Chemotherapy in Recurrent/Metastatic Nasopharyngeal Cancer in KEYNOTE-122. Cancer Med Chan ATC, Lee VHF, Hong RL, Ahn MJ, Chong WQ, Spreafico A, Kim SB, Ho GF, Caguioa PB, Ngamphaiboon N, Swaby RF, Wei B, Webber AL, Kang J, Gumuscu B, Yuan J, Siu LL. PMID: 41631899 [PubMed - indexed for MEDLINE]
	Artificial intelligence-assisted real-time nasopharyngeal cancer diagnostic model enhances rhinologist performance: a prospective multi-reader study. Ann Med He R, Jie P, Wang Z, Lu Y, Lv H, Huang Z, Liu W, Wang Y, Liu W, Lei W, Wen W, Wen Y. PMID: 41630445 [PubMed - indexed for MEDLINE]
	MRI-based deep learning model predicts recurrent nasopharyngeal carcinoma in post-radiation nasopharyngeal necrosis. Comput Med Imaging Graph Lin C, Liang JL, Guo J, Xie YL, Cheng W, Huang GH, Lin QW, Chen JW, Xiang T, Mai HQ, Yang Q. PMID: 41621202 [PubMed - indexed for MEDLINE]
	Comparison of Local Control and Toxicity in T4 Nasopharyngeal Carcinoma Patients Treated with Induction Chemotherapy and Intensity-Modulated Radiotherapy: Conventional vs. Hyperfractionated Regimens. Medicina (Kaunas) Hsieh HY, Lin JC, Chang HH. PMID: 41597363 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 9014

Seite 1 von 451

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung